Prevalence estimates on Rare Medical Network websites are calculated based on data available from numerous sources, including US and European government statistics, the NIH, Orphanet, and published epidemiologic studies. Rare disease population data is recognized to be highly variable, and based on a wide variety of source data and methodologies, so the prevalence data on this site should be assumed to be estimated and cannot be considered to be absolutely correct.
Age of Onset
B43.0 B43.1 B43.2 B43.8 B43.9
Autosomal dominant ?A pathogenic variant in only one gene copy in each cell is sufficient to cause an autosomal dominant disease
Autosomal recessive ?Pathogenic variants in both copies of each gene of the chromosome are needed to cause an autosomal recessive disease and observe the mutant phenotype
X-linked dominant ?X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
X-linked recessive ?Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder
Mitochondrial or multigenic ?Mitochondrial genetic disorders can be caused by changes (mutations) in either the mitochondrial DNA or nuclear DNA that lead to dysfunction of the mitochondria and inadequate production of energy.
Multigenic or multifactor ?Inheritance involving many factors, of which at least one is genetic but none is of overwhelming importance, as in the causation of a disease by multiple genetic and environmental factors.
Other Names (AKA)
Chromoblastomycosis is a chronic fungal infection characterized by raised and crusted lesions which affect the skin and subcutaneous
This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.
|Medical Terms||Other Names||
|80%-99% of people have these symptoms|
[ more ]
|30%-79% of people have these symptoms|
|Abnormal foot morphology||
Abnormal feet structure
Abnormality of the feet
Abnormality of the foot
[ more ]
|Annular cutaneous lesion||0025528|
|Predominantly lower limb lymphedema||0003550|
|Serpiginous cutaneous lesion||0025527|
Firm lump under the skin
Growth of abnormal tissue under the skin
[ more ]
|5%-29% of people have these symptoms|
|Abnormality of the upper limb||0002817|
|Atypical scarring of skin||
|Hypopigmented skin patches||
Patchy loss of skin color
|Recurrent bacterial infections||
Bacterial infections, recurrent
Frequent bacterial infections
Increased susceptibility to bacterial infections
Recurrent major bacterial infections
[ more ]
|Vascular skin abnormality||0011276|
|1%-4% of people have these symptoms|
|Abnormal lung morphology||
Abnormality of lung structure
Abnormality of the lungs
Abnormally shaped lung
Unusal lung shape
[ more ]
|Abnormal oral cavity morphology||
Abnormality of the oral cavity
Eyelid turned out
|Facial shape deformation||0011334|
Decreased immune function
|Multiple cutaneous malignancies||0007606|
Breakdown of bone
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
- DermNet NZ is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- The Merck Manual for health care professionals provides information on Chromoblastomycosis.
- The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Chromoblastomycosis. Click on the link to view a sample search on this topic.
- The The Global Action Fund for Fungal Infections links to a factsheet on Chromoblastomycosis
- Chromoblastomycosis. DermNet NZ. December 29, 2013; https://www.dermnetnz.org/fungal/chromoblastomycosis.html. Accessed 12/16/2014.
- Revankar SG, Sobel JD. Chromoblastomycosis. The Merck Manual Professional Edition. January 2014; https://www.merckmanuals.com/professional/infectious_diseases/fungi/chromoblastomycosis.html. Accessed 12/16/2014.